|
US5643578A
(en)
|
1992-03-23 |
1997-07-01 |
University Of Massachusetts Medical Center |
Immunization by inoculation of DNA transcription unit
|
|
US6165993A
(en)
*
|
1992-03-23 |
2000-12-26 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
US5620896A
(en)
*
|
1992-03-23 |
1997-04-15 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
US6127116A
(en)
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
|
GB9709900D0
(en)
*
|
1997-05-15 |
1997-07-09 |
Microbiological Res Authority |
Microencapsulated DNA for vaccination and gene therapy
|
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
|
EP0862419B2
(en)
*
|
1995-11-09 |
2010-11-17 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
|
US5741492A
(en)
*
|
1996-01-23 |
1998-04-21 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
US6723558B1
(en)
|
1996-01-23 |
2004-04-20 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
AU2118997A
(en)
*
|
1996-02-05 |
1997-08-22 |
Johns Hopkins University, The |
Measles immunization by dna transcription unit inoculation
|
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
HRP970092A2
(en)
*
|
1996-02-22 |
1998-04-30 |
Merck & Co Inc |
Synthetic hiv genes
|
|
EP0912607A2
(en)
*
|
1996-06-21 |
1999-05-06 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
AU3514197A
(en)
|
1996-07-03 |
1998-01-21 |
Genetics Institute Inc. |
Protease fmh-1, an ice/ced-like protease
|
|
FR2751224B1
(fr)
*
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
|
|
FR2751225B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique aviaire
|
|
US7294338B2
(en)
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
FR2751226B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies du cheval
|
|
FR2751227B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
FR2751229B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
|
|
FR2751228B1
(fr)
*
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Vaccin polynucleotidique bovin pour voie intradermique
|
|
FR2751223B1
(fr)
*
|
1996-07-19 |
1998-12-04 |
Rhone Merieux |
Formule de vaccin polynucleotidique felin
|
|
US5783567A
(en)
*
|
1997-01-22 |
1998-07-21 |
Pangaea Pharmaceuticals, Inc. |
Microparticles for delivery of nucleic acid
|
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
|
CN1044092C
(zh)
|
1997-02-26 |
1999-07-14 |
上海医科大学 |
抗原－抗体－重组dna复合型疫苗
|
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
UA78180C2
(uk)
|
1997-10-03 |
2007-03-15 |
Меріаль |
Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
|
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
US6548302B1
(en)
|
1998-06-18 |
2003-04-15 |
Johns Hopkins University School Of Medicine |
Polymers for delivery of nucleic acids
|
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
|
GB9818627D0
(en)
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
WO2000047227A2
(en)
|
1999-02-09 |
2000-08-17 |
Powderject Vaccines, Inc. |
Mycobacterium tuberculosis, immunization
|
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
AUPS054702A0
(en)
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
|
US6982156B2
(en)
|
2002-03-27 |
2006-01-03 |
Trustees Of The University Of Pennsylvania |
Compositions and methods modulating variola and vaccinia virus
|
|
US6783759B2
(en)
|
2002-03-27 |
2004-08-31 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for modulating variola virus
|
|
WO2005035771A2
(en)
|
2003-10-10 |
2005-04-21 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
PL1692516T3
(pl)
|
2003-10-24 |
2011-05-31 |
Immunaid Pty Ltd |
Sposób terapii
|
|
AU2005249450A1
(en)
|
2004-05-27 |
2005-12-15 |
Centocor, Inc. |
Cynomolgus prostate specific antigen
|
|
US20060121031A1
(en)
|
2004-12-07 |
2006-06-08 |
Mckenzie Brent S |
Relay vaccine
|
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
|
US8263088B2
(en)
|
2007-06-08 |
2012-09-11 |
Australian Poultry Crc Pty Ltd. |
Clostridial toxin NetB
|
|
BRPI0815848A2
(pt)
|
2007-08-30 |
2017-06-06 |
The Burnet Inst |
composto, linhagem de célula que produz anticorpo estável, composição, métodos para modular uma resposta imune em um indivíduo e para tratar e/ou prevenir uma doença, usos de um composto e/ou uma composição e de células dendríticas ou precursores das mesmas, métodos para enriquecer e detectar células dendríticas ou um subconjunto ou precursores das mesmas, polipeptídeo, polinucleotídeo vetor, célula hospedeira, planta transgênica, animal não humano transgênico, extrato, processo para preparar um composto ou um polipeptídeo, população enriquecida de células dendríticas e/ou precursores das mesmas, população de célula dendrítica expandida e/ou precursores das mesmas, métodos para identificar uma molécula que se liga a um polipeptídeo e para triar quanto a um composto que se liga a um polipeptídeo, uso de um polipeptídeo, um polinucleotídeo, um vetor, uma célula hospedeira, uma planta transgênica, um extrato, uma população de célula e/ou uma composição, método para produzir um composto, e, kit.
|
|
HUE026456T2
(en)
|
2009-05-27 |
2016-05-30 |
Biotempus Ltd |
Methods of treating diseases
|
|
TWI627281B
(zh)
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
|
|
WO2011140595A2
(en)
|
2010-05-10 |
2011-11-17 |
4G Vaccines Pty Ltd |
Immunostimulatory and vaccine compositions
|
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
|
AU2012327878A1
(en)
|
2011-10-28 |
2014-05-29 |
Patrys Limited |
PAT-LM1 epitopes and methods for using same
|
|
MX360137B
(es)
|
2013-02-21 |
2018-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento.
|
|
AU2015241107B2
(en)
|
2014-04-03 |
2019-10-03 |
Boehringer Ingelheim Animal Health USA Inc. |
Porcine epidemic diarrhea virus vaccine
|
|
BR112016030728A2
(pt)
|
2014-06-30 |
2018-02-20 |
Murdoch Childrens Research Institute |
método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença
|
|
KR20180042167A
(ko)
|
2015-08-31 |
2018-04-25 |
베링거잉겔하임베트메디카게엠베하 |
선천성 진전을 위한 페스티바이러스 백신
|
|
US20170072042A1
(en)
|
2015-09-16 |
2017-03-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Salmonella choleraesuis-salmonella typhimurium vaccines
|
|
WO2018054822A1
(en)
|
2016-09-20 |
2018-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
New swine influenza vaccine
|
|
KR102543774B1
(ko)
|
2016-09-20 |
2023-06-19 |
베링거잉겔하임베트메디카게엠베하 |
신규한 프로모터
|
|
AR109539A1
(es)
|
2016-09-20 |
2018-12-19 |
Boehringer Ingelheim Vetmedica Gmbh |
Sitio de inserción orf70 de ehv
|
|
ES2956050T3
(es)
|
2016-09-20 |
2023-12-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Vectores de adenovirus caninos
|
|
EP4570264A3
(en)
|
2016-11-03 |
2026-01-21 |
Boehringer Ingelheim Vetmedica GmbH |
Vaccine against porcine parvovirus
|
|
PL3534939T3
(pl)
|
2016-11-03 |
2023-06-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Szczepionka przeciw parwowirusowi świń i wirusowi zespołu rozrodczo-oddechowego świń oraz sposoby ich wytwarzania
|
|
CA3046684A1
(en)
|
2017-01-30 |
2018-08-02 |
Boehringer Ingelheim Animal Health USA Inc. |
Porcine coronavirus vaccines
|
|
US11179457B2
(en)
|
2017-07-12 |
2021-11-23 |
Boehringer Ingelheim Animal Health USA Inc. |
Senecavirus a immunogenic compositions and methods thereof
|
|
JP7038804B2
(ja)
|
2017-09-23 |
2022-03-18 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
パラミクソウイルス科の発現系
|
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
|
BR112020017239A2
(pt)
|
2018-02-23 |
2020-12-22 |
Boehringer Ingelheim Vetmedica Gmbh |
Sistemas de vetor viral recombinante que expressam genes de paramixovírus felino exógenos e vacinas feitas a partir deles
|
|
JP7245260B2
(ja)
|
2018-03-19 |
2023-03-23 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
Ｅｈｖ挿入部位ｕｌ４３
|
|
BR112020019268A2
(pt)
|
2018-03-19 |
2021-01-05 |
Boehringer Ingelheim Vetmedica Gmbh |
Novo ehv com ul18 e/ou ul8 inativados
|
|
CN119488586A
(zh)
|
2018-03-26 |
2025-02-21 |
勃林格殷格翰动物保健美国有限公司 |
制备免疫原性组合物的方法
|
|
JP7284822B2
(ja)
|
2018-09-20 |
2023-05-31 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
改変ｐｅｄｖスパイクタンパク質
|
|
WO2020058341A1
(en)
|
2018-09-20 |
2020-03-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Intranasal vector vaccine against porcine epidemic diarrhea
|
|
US11858962B2
(en)
|
2020-02-06 |
2024-01-02 |
Boehringer Ingelheim Vetmedica Gmbh |
Polypeptides useful for detecting anti-rhabdovirus antibodies
|
|
US20220160866A1
(en)
|
2020-10-05 |
2022-05-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Fusion protein useful for vaccination against rotavirus
|
|
EP4225361A1
(en)
|
2020-10-05 |
2023-08-16 |
Boehringer Ingelheim Animal Health USA Inc. |
Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof
|
|
CA3255048A1
(en)
|
2022-04-05 |
2023-10-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic composition useful for rotavirus vaccination
|